IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

about

Single cell analysis of kynurenine and System L amino acid transport in T cells.Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?

P2860

Q55317813-E6EA38DF-FF99-4708-BFE1-2AB7C075C5C2 Q58750429-A0C234A3-62E8-42A7-B37F-717D4C395A12 Q58799410-41DB2B5E-D18D-4E1A-9CF8-5D45C807DB23

P2860

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

Item

http://www.wikidata.org/entity/Q50103704

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@en

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@nl

type

Item

label

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@en

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@nl

prefLabel

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@en

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@nl

P1476

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

@en

P2093

Andrew L Mellor

http://www.w3.org/2001/XMLSchema#string

Huanmei Wu

http://www.w3.org/2001/XMLSchema#string

Jian-Yue Jin

http://www.w3.org/2001/XMLSchema#string

Lang Li

http://www.w3.org/2001/XMLSchema#string

Li Yan

http://www.w3.org/2001/XMLSchema#string

Shruti Jolly

http://www.w3.org/2001/XMLSchema#string

Wenhu Pi

http://www.w3.org/2001/XMLSchema#string

Yong Zang

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity

Trial watch: IDO inhibitors in cancer therapy

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

Immunologic correlates of the abscopal effect in a patient with melanoma

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.

Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach.

IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.

P304

809-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-17-2995

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Weili WANG

Feng-Ming Spring Kong

Lei Huang

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29118088

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5811356

http://www.w3.org/2001/XMLSchema#string

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

about

P2860

P2860

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932